Research News

DORIS DUKE CHARITABLE FOUNDATION (DDCF) – CLINICAL SCIENTIST DEVELOPMENT AWARD

Purpose: Physician scientists pursuing research careers face challenges that are particular to their dual roles as researchers and health care providers. The purpose of the Doris Duke Clinical Scientist Development…

American Diabetes Association – PostDoc Fellow Research

Purpose: The American Diabetes Association (ADA), through support provided by Pfizer, Inc., is now requesting applications for postdoctoral fellows proposing basic, clinical and translational research focused on cardiovascular disease in…

NIH – Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Purpose: The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of…

NIH – Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists,…

NIH – Institutional Research and Academic Career Development Awards (IRACDA) (K12 – Independent Clinical Trial Not Allowed)

Purpose: The Institutional Research and Academic Career Development Award (IRACDA) Program provides support for a mentored postdoctoral research experience at a research-intensive institution combined with an opportunity to develop critical…

NIH – NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed)

Purpose: The NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience related research, with the aim of accelerating discoveries…

NIH – Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement (FOA) invites researchers to submit applications for multidisciplinary diagnostic strategies for rare diseases that combine machine-assistance, genomic analysis, and clinical consultation. Of particular importance, these…

Conquer Cancer – Various Awards

Early-Career Awards: Career Development Award (CDA) in Palliative and Supportive Care in Oncology Grant Amount: $200,000 | Application Deadline: September 24th Career Development Award (CDA) (for all subject areas) Grant…

Melanoma Research Alliance – Brain Metastisis

Purpose: The Melanoma Research Alliance (MRA) is pleased to announce a Second Release of its Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to…

AHRQ – Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support

Purpose: This Funding Opportunity Announcement (FOA) invites R18 grant applications that disseminate and implement patient-centered outcomes research (PCOR) evidence into clinical practice through clinical decision support (CDS). AHRQ seeks projects…

National Multiple Sclerosis Society – Biostatistics/Informatics Junior Faculty Award

Purpose: As part of our commitment to building a workforce of research leaders to drive pathways to MS cures, the National MS Society established a junior faculty award in biostatistics/…

NIH – Multiple Emergency Awards re: SARS-CoV-2/COVID-19

Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) (RFA-OD-20-014) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute National Institute…

NIH – Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)

Purpose: The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and…

NIH – Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)

Purpose: The purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result…

NIH – Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01 Clinical Trial Optional)

Purpose: The purpose of this initiative is to support investigator-initiated research on genetic counseling processes and practices in genomic medicine. Research is needed to optimize the genetic counseling process in…

NIH – Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities…

Melanoma Research Alliance – pre-clinical, translational, and early clinical research

Purpose: The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact,…

NIH – Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Purpose: Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) along with the National Human Genome Research Institute (NHGRI) and National Institute of Dental and Craniofacial Research (NIDCR)…

Stand Up To Cancer (SU2C) – Health Equity Breakthrough Team Research Grant Program

Purpose: The Breakthrough Team represents an unprecedented opportunity to bring together the best scientific minds from diverse fields of research to concentrate on new approaches to address health equity in…

NINDS Exploratory Grant Program in Parkinson’s Disease Research (P20- Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) invites Exploratory Grant (P20) applications for the planning and initiation of collaborative efforts to advance Parkinson’s Disease (PD) research. The goal of this program…

NIH – Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)…

NIH – Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

Purpose: This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations…

NIH – Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)

Purpose: This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity,…

Ovarian Cancer Research Alliance – Multiple Funding Opportunities

Purpose: Ovarian Cancer Research Alliance is the largest global charity funding ovarian cancer research. In the U.S., OCRA is the largest non-government funder of ovarian cancer research.  OCRA grant programs…

Gateway for Cancer Research – Continuity of patient access to clinical trials during Pandemic

PURPOSE: The oncology community must continue to urgently respond to the significant disruption of clinical trials caused by the COVID-19 pandemic. To that end, Gateway for Cancer Research is committing…